Lumira Ventures
Finance · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
141 Adelaide St W Ste 770, Toronto, Onta...Phone Number
(781) 530-3868Website
www.lumiraventures.comRevenue
$7.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
2
1
1
1
About Lumira Ventures
Lumira Ventures is Canada's largest life sciences venture capital firm, specializing in investments in healthcare innovators across various stages, from early-stage to revenue-generating biotech, biotherapeutics, and medical devices. The firm partners with mission-driven entrepreneurs to develop and commercialize impactful products aimed at improving patient outcomes. Headquartered in Toronto, Ontario, Lumira Ventures also has locations in Montreal, Vancouver, and Boston. Their portfolio includes notable companies and collaborations, such as the Cancer Breakthrough Fund with The Terry Fox Foundation.Explore more
Lumira Ventures Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lumira Ventures your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Lumira Ventures
Lumira Ventures, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Lumira Ventures is spiking on competitors!
Click to see if Lumira Ventures had a recent Job posting/layoffs
Check if Lumira Ventures has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Lumira Ventures recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Lumira Ventures has new funding data
Product Launch: Get notified when Lumira Ventures launches new products
Recommended Actions
Reach out to Masked Content who joined Lumira Ventures as Masked Content
Find 2 more new buyers
Compare Similar Companies to Lumira Ventures
Compare insights from companies similar to Lumira Ventures, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Lumira Ventures is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Lumira Ventures is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Lumira Ventures.
Lumira Ventures Tech Stack
A closer look at the technologies used by Lumira Ventures
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Lumira Ventures News & Media
Specific Biologics Announces Additional Investment and Appointment of Experienced Biotechnology Leader Steven Kanner, PhD, to the Board of Directors
Specific Biologics is an early-stage biotechnology company developing its proprietary two-site Dualase® platform gene editors to build a pipeline of treatments for serious genetic diseases. TORONTO, Oct. 10, 2023 /PRNewswire/ - Specific Biologics Inc. ("Specific"), a venture-backed,...Antiva Biosciences Closes $53M Series E Equity Financing
Antiva Biosciences, a South San Francisco, CA-based biopharmaceutical company developing topical therapeutics for the treatment of pre-cancerous lesions caused by human papilloma virus (HPV) infection, raised $53M in Series E funding. The round was led by MPM-BioImpact Capital, and joined by existing investors including Canaan Partners, Sofinnova Investments, Adjuvant Capital, GV and Lumira Ventures, among others. The company […] The post Antiva Biosciences Closes $53M Series E Equity FinancingLumira Ventures Updates Holdings in Edesa Biotech, Inc.
Lumira Capital Investment Management Inc. o/a Lumira Ventures ("Lumira") announces that on January 9, 2023, 132,845 common shares ("Common Shares") of Edesa Biotech, Inc. (the "Issuer") and 12,284 Common Shares were sold by Lumira Capital II, L.P. ("LCII LP") and Lumira Capital II (International), L.P. ("LCII INT LP"), respectively, at a price of US$2.6621 per Common Share, and on January 10, 2023, 139,450 Common Shares and 12,895 Common Shares were sold by LCII LP andHistoSonics Raises $100M in Financings
HistoSonics, an Ann Arbor, Michigan and Minneapolis, MN-based developer of a non-invasive, novel sonic beam therapy, raised $100M in equity and debt. The $85M equity round was led by Johnson & Johnson Innovation with participation from Venture Investors, Lumira Ventures, Yonjin Venture, and the State of Wisconsin Investment Board. Concurrently, the company also secured a commitment for […] The post HistoSonics Raises $100M in Financings appeared first on FinSMEs.
Read more news
Top Finance Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Lumira Ventures
Sign Up For FreeTo access detailed company insights
Lumira Ventures is Canada's largest life sciences venture capital firm, specializing in investments in healthcare innovators across various stages, from early-stage to revenue-generating biotech, biotherapeutics, and medical devices. The firm partners with mission-driven entrepreneurs to develop and commercialize impactful products aimed at improvi... Read More
